Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum — Mechanisms, evidence, and future directions
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum — Mechanisms, evidence, and future directions. // Clinical Parkinsonism & Related Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S2590112526000411?dgcid=rss_sd_all
Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum — Mechanisms, evidence, and future directions. Clinical Parkinsonism & Related Disorders. https://www.sciencedirect.com/science/article/pii/S2590112526000411?dgcid=rss_sd_all
“Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum — Mechanisms, evidence, and future directions.” Clinical Parkinsonism & Related Disorders.
@article{article97750,
title = {Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum — Mechanisms, evidence, and future directions},
journal = {Clinical Parkinsonism \& Related Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S2590112526000411?dgcid=rss_sd_all}
}